Literature DB >> 30705042

Retinal microvascular abnormalities in neurofibromatosis type 1.

Antonietta Moramarco1, Emanuele Miraglia2, Fabiana Mallone3, Vincenzo Roberti2, Chiara Iacovino2, Alice Bruscolini3, Rosalia Giustolisi3,4, Sandra Giustini2,5.   

Abstract

PURPOSE: The aim of this study was to provide a classification of the different retinal vascular arrangements in neurofibromatosis 1 (NF1), with appropriate qualitative and quantitative information.
METHODS: This study was conducted on 334 consecutive patients with NF1 and 106 sex-matched and age-matched healthy control subjects. Each patient underwent a comprehensive ophthalmological examination inclusive of near-infrared reflectance retinography by using the spectral domain Optical coherence tomography (OCT), a complete dermatological examination and 1.5 T MRI scan of the brain to assess the presence of optic nerve gliomas. To evaluate the predictability and the diagnostic accuracy of our identified retinal microvascular arrangements, we calculated the diagnostic indicators for each pattern of pathology, with corresponding 95% CI. In addition, we evaluated the association between the microvascular arrangements and each National Institutes of Health diagnostic criteria.
RESULTS: Microvascular abnormalities were detected in 105 of 334 NF1 patients (31.4%), the simple vascular tortuosity was recognised in 78 of 105 cases (74.3%) and whether the corkscrew pattern and the moyamoya-like type showed a frequency of 42.8% (45 of 105 cases) and 15.2% (16 of 105 cases), respectively. We found a statistically significant correlation between the presence of retinal microvascular abnormalities and the patient age (p=0.02) and between the simple vascular tortuosity, the patient age and the presence of neurofibromas (p=0.002 and p=0.05, respectively).
CONCLUSIONS: We identified microvascular alterations in 31.4% of patients and a statistically significant association with patient age. Moreover, the most frequent type of microvascular alterations, the simple vascular tortuosity, resulted positively associated with age and with the presence of neurofibromas. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  NF1; NIR-OCT; microvascular abnormalities; moya-moya disease; ophthalmoscopy; retina

Mesh:

Year:  2019        PMID: 30705042     DOI: 10.1136/bjophthalmol-2018-313002

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  5 in total

1.  Unilateral vascular abnormality: A case of peripheral retinal arteriolar tortuosity associated with a prepapillary vascular loop.

Authors:  Parth S Patel; Mansoor Mughal; Harold M Wheatley; Jonathan L Prenner
Journal:  Am J Ophthalmol Case Rep       Date:  2020-08-13

2.  Neurofibromatosis Type 1: Ocular Electrophysiological and Perimetric Anomalies.

Authors:  Marcella Nebbioso; Antonietta Moramarco; Alessandro Lambiase; Sandra Giustini; Marco Marenco; Emanuele Miraglia; Pasquale Fino; Chiara Iacovino; Ludovico Alisi
Journal:  Eye Brain       Date:  2020-10-21

3.  An update on choroidal abnormalities and retinal microvascular changes in neurofibromatosis type 1.

Authors:  Fabiana Mallone; Luca Lucchino; Sandra Giustini; Alessandro Lambiase; Antonietta Moramarco
Journal:  Orphanet J Rare Dis       Date:  2022-06-13       Impact factor: 4.303

4.  Hyperpigmented spots at fundus examination: a new ocular sign in Neurofibromatosis Type I.

Authors:  Antonietta Moramarco; Fabiana Mallone; Marta Sacchetti; Luca Lucchino; Emanuele Miraglia; Vincenzo Roberti; Alessandro Lambiase; Sandra Giustini
Journal:  Orphanet J Rare Dis       Date:  2021-03-23       Impact factor: 4.123

5.  Diagnosis and clinical course of ocular ischemic syndrome with retinal vascular abnormalities due to unilateral ocular artery and internal carotid artery stenosis in a child with neurofibromatosis type 1: a case report.

Authors:  Hiroaki Sakai; Kosuke Kawata; Jun Masuoka; Tomohisa Nishimura; Hiroshi Enaida
Journal:  BMC Ophthalmol       Date:  2020-10-23       Impact factor: 2.209

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.